Targeted drug for leukemia tested at Penn Medicine helps patients live longer

(University of Pennsylvania School of Medicine) An inhibitor drug that targets a specific mutation in relapsed or refractory acute myeloid leukemia (AML) helps patients live almost twice as long as those who receive chemotherapy.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news